Parian Global Management’s Rapid Micro Biosystems RPID Stock Holding History

Parian Global Management’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$129K	Buy	+40,000	New	+$155K	0.42%	27

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Parian Global Management's RPID Position: Q3 2022 in Review

Parian Global Management opened a new position in Rapid Micro Biosystems (RPID) in Q3 2022: 40,000 shares worth $129K. The stake represents 0.42% of the portfolio and ranks #27 among its holdings.

53 funds tracked by Wall St. Rank hold RPID as of Q3 2022.

Parian Global Management held 40,000 shares of Rapid Micro Biosystems worth $129K as of Q3 2022.
Rapid Micro Biosystems was a new Parian Global Management position in Q3 2022.
Rapid Micro Biosystems made up 0.42% of Parian Global Management's portfolio in Q3 2022, its #27 holding.
53 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q3 2022.

Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.